Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
Mouse Monoclonal [clone I8-60] (IgG1,k) to Human IL8 / Interleukin 8
Western blot, ELISA, Neutralization
Human IL8 / Interleukin 8
Human (tested or 100% immunogen sequence identity)
IgG1,k Monoclonal [I8-60]
Protein G purified
Western blot (0.02 - 0.1 µg/ml)
IHC - Paraffin
Specificity and Use
IL8 / Interleukin 8 antibody was raised against purified recombinant human IL-8.
Recognizes recombinant and native human IL-8. Does not cross-react with human Monocyte Chemotactic Activating Factor (MCAF) or RANTES (Regulated on Activation, Normal T-cell Expressed and Secreted).
Suitable for use in ELISA, Neutralizing and Western Blot. Western Blot: 0.02-0.1 ug/ml allows visualization of 100 ng/lane of human IL-8. Can be used as a detection antibody in a sandwich ELISA along with LS-C8024 as the capture antibody.
PBS, pH 7.0
Long term: -20°C; Short term: +4°C. Avoid repeat freeze-thaw cycles.
Interleukin 8 (IL8), a member of the CXC chemokine family. This chemokine, is one of the major mediators of the inflammatory response. This chemokine is secreted by several cell types. It functions as a chemoattractant, and is also a potent angiogenic factor. This gene is believed to play a role in the pathogenesis of bronchiolitis, a common respiratory tract disease caused by viral infection.